Screening compound: UGNPGLJGCKPZTB-HSZRJFAPSA-N

Screening compound: UGNPGLJGCKPZTB-HSZRJFAPSA-N
Screening compound: UGNPGLJGCKPZTB-HSZRJFAPSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
UGNPGLJGCKPZTB-HSZRJFAPSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C390-0524

Molecular Formula

C25H21N3O5S (C25 H21 N3 O5 S)

Compound Name

ethyl 4-[4-(4-hydroxy-3-methoxyphenyl)-6-oxo-3-(thiophen-2-yl)-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-5-yl]benzoate

IUPAC name

ethyl 4-[4-(4-hydroxy-3-methoxyphenyl)-6-oxo-3-(thiophen-2-yl)-1H4H5H6H-pyrrolo[34-c]pyrazol-5-yl]benzoate

SMILES

CCOC(c(cc1)ccc1N(C(c1c2[nH]nc1-c1cccs1)c(cc1)cc(OC)c1O)C2=O)=O

InChI

InChI=1S/C25H21N3O5S/c1-3-33-25(31)14-6-9-16(10-7-14)28-23(15-8-11-17(29)18(13-15)32-2)20-21(19-5-4-12-34-19)26-27-22(20)24(28)30/h4-13,23,29H,3H2,1-2H3,(H,26,27)/t23-/m1/s1

InChI Key

UGNPGLJGCKPZTB-HSZRJFAPSA-N

MDL Number (MFCD)

MFCD09661522

UGNPGLJGCKPZTB-HSZRJFAPSA-N in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Anticancer Library (62698 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Human Kinases Annotated Library (2415 compounds)

Human Proteases Annotated Library (2868 compounds)

Selective Target Activity Profiling Library (14702 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Cancer
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators

References: we are preparing a list of scientific research reports with UGNPGLJGCKPZTB-HSZRJFAPSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound UGNPGLJGCKPZTB-HSZRJFAPSA-N?
Check Price and Availability of UGNPGLJGCKPZTB-HSZRJFAPSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of UGNPGLJGCKPZTB-HSZRJFAPSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for UGNPGLJGCKPZTB-HSZRJFAPSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for UGNPGLJGCKPZTB-HSZRJFAPSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of UGNPGLJGCKPZTB-HSZRJFAPSA-N available by request